덱스컴(주)
DE ˙ DB ˙ US2521311074
€63.20 ↑1.00 (1.61%)
2026-06-05
주가
SecurityDE:DC4 / DexCom, Inc.
InstitutionCovestor Ltd
Latest Disclosed Ownership194 shares
Latest Disclosed Value $ 12
Covestor Ltd reports 20.16% decrease in ownership of DC4 / DexCom, Inc.

On May 5, 2026 - Covestor Ltd filed a 13F-HR form disclosing ownership of 194 shares of DexCom, Inc. (DE:DC4) valued at $10,513 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 243 shares of DexCom, Inc.. The current value of the position is $12,261 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F DEXCOM COMMON 252131107 194 -49 -20.16 0 0.0083
2026-02-06 2025-12-31 13F DEXCOM COMMON 252131107 243 -13 -5.08 0 0.0084
2025-10-30 2025-09-30 13F DEXCOM COMMON 252131107 256 -297 -53.71 0 0.0094
2025-08-11 2025-06-30 13F DEXCOM COMMON 252131107 553 -324 -36.94 0 0.0283
2025-05-12 2025-03-31 13F DEXCOM COMMON 252131107 877 -232 -20.92 0 0.0400
2025-02-13 2024-12-31 13F DEXCOM COMMON 252131107 1,109 150 15.64 0 0.0539
2024-11-01 2024-09-30 13F DEXCOM COMMON 252131107 959 335 53.69 0 0.0401
2024-08-09 2024-06-30 13F DEXCOM COMMON 252131107 624 -225 -26.50 0 0.0459
2024-05-10 2024-03-31 13F DEXCOM COMMON 252131107 849 15 1.80 0 0.0749
2024-02-09 2023-12-31 13F DEXCOM COMMON 252131107 834 541 184.64 0 0.0711
2023-11-13 2023-09-30 13F DEXCOM COMMON 252131107 293 -276 -48.51 0 0.0204
2023-08-11 2023-06-30 13F DEXCOM COMMON 252131107 569 390 217.88 0 0.0556
2023-05-15 2023-03-31 13F DEXCOM COMMON 252131107 179 7 4.07 0 -100.00 0.0183
2023-02-14 2022-12-31 13F/A-1 DEXCOM COMMON 252131107 172 0 0.00 20 42.86 0.0163
2023-02-14 2022-12-31 13F DEXCOM COMMON 252131107 172 0 20 16.3090
2022-11-14 2022-09-30 13F DEXCOM COMMON 252131107 172 -3 -1.71 14 7.69 0.0123
2022-08-10 2022-06-30 13F DEXCOM COM 252131107 175 129 280.43 13 -45.83 0.0103
2022-05-13 2022-03-31 13F DEXCOM COM 252131107 46 -86 -65.15 24 -66.20 0.0160
2022-02-10 2021-12-31 13F DEXCOM COM 252131107 132 132 71 0.0995
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.